Prostate specific antigen (PSA)

Reference

Reference
Morote J, Raventós CX, Lorente JA et al , 1999, Eur Urol, 36(2), 111-5 , Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination

Scoring

Total Score

C2,6,7,8,10,11,12,13

Parameter Score
1. Scale A
2. Study Population C
3. Samples B
4. Measurand A
5. Pre-Analytical A
6. Replicate Analysis C
7. Steady State C
8. Outlier Analysis C
9. Normality B
10. Variance Homogeneity C
11. ANOVA C
12. CI C
13. No of Results C
14. Concentrations B
15. Total Score C2,6,7,8,10,11,12,13
Comment

Item Details

Parameter Score
Matrix Serum
Measurand Prostate specific antigen (PSA)
Unit ng / mL
Overall Analytical Principle Method Immunoassay; Other
Number of Subjects 19
Number of Subjects included in BV estimation 19
Ethinicity Unknown
Age Mean / Median
Age Min
Age Max
Age SD
Number of Males 19
Number of Females 0
State of Well Being
Non-healthy (excl pregnant)
Diseases
Study Duration Length 3
Study Duration Units Year
Sampling Intervals, e.g. X sample(s) per Interval Unit 60
Interval Units Day
Sampling Times Start Time:
End Time:
Number of Samples 2
Average Number of Samples Used for BV Estimation 2.0
Average Number of Replicates 1.0
Estimates of CVi 19.6
Calculated Confidence Intervals of CVi Lower: 12.51, Upper: 28.92
Estimates of CVg
Calculated Confidence Intervals of CVg Lower: , Upper:
Analytical CV 4.0
Calculated Confidence Intervals of Analytical CV Lower: 2.27, Upper: 14.92
Measurand Mean
Measurand Min 0.0
Measurand Max 4.0
Measurand SD

Coding